This topic contains a solution. Click here to go to the answer

Author Question: Collusion among firms to raise price is rare in monopolistically competitive markets because a. ... (Read 29 times)

rlane42

  • Hero Member
  • *****
  • Posts: 594
Collusion among firms to raise price is rare in monopolistically competitive markets because
 a. there are too many firms
  b. there are too few firms
  c. there is only one firm
  d. products are homogeneous
  e. price leadership is used instead

Question 2

Which of the following did not contribute to the increase in competition in the United States between 1958 and 1988?
 a. antitrust activity
  b. deregulation of transportation industries
  c. deregulation of banking
  d. increased imports
  e. conglomerate mergers



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yasmina

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

A

Answer to Question 2

E




rlane42

  • Member
  • Posts: 594
Reply 2 on: Jun 30, 2018
Excellent


amcvicar

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

For a complete list of videos, visit our video library